We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+0.1%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.97B
AUM Growth
-$227M
(-4.4%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-2.42%
Top 10 Holdings %
Top 10 Hldgs %
24.91%
Holding
802
New
109
Increased
252
Reduced
267
Closed
54
Avg Time Held
1.6
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ventas
VTR
|
+$29.1M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$28.3M |
| 3 |
Ecolab
ECL
|
+$25.4M |
| 4 |
Merck
MRK
|
+$24.7M |
| 5 |
Edwards Lifesciences
EW
|
+$20.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ServiceNow
NOW
|
+$44M |
| 2 |
SBA Communications
SBAC
|
+$43.3M |
| 3 |
Chipotle Mexican Grill
CMG
|
+$42M |
| 4 |
TD Ameritrade Holding Corp
AMTD
|
+$40.5M |
| 5 |
Gilead Sciences
GILD
|
+$39.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.75% |
| 2 | Consumer Discretionary | 15.42% |
| 3 | Technology | 15.27% |
| 4 | Financials | 12.99% |
| 5 | Industrials | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
Canadian Pacific Kansas City
CP
$76.4B
| $841K | 0.02% |
31,675
+11,050
| +54% | +$269K |
2013 Q4
9 quarters
|
|
302
Lowe's Companies
LOW
$110B
| $823K | 0.02% |
10,867
-2,832
| -21% | -$200K |
2013 Q2
11 quarters
|
|
303
Omnicell
OMCL
$1.64B
| $816K | 0.02% |
29,272
-1,394
| -5% | -$38.3K |
2015 Q4
1 quarter
|
|
304
Diamondback Energy
FANG
$54.8B
| $812K | 0.02% |
10,520
-495
| -4% | -$34.9K |
2014 Q4
5 quarters
|
|
|
PACW
305
DELISTED
PacWest Bancorp
PACW
| $812K | 0.02% |
21,845
+14,855
| +213% | +$526K |
2015 Q4
1 quarter
|
|
|
MINI
306
DELISTED
Mobile Mini Inc
MINI
| $804K | 0.02% |
24,339
+10,132
| +71% | +$286K |
2015 Q4
1 quarter
|
|
307
Protolabs
PRLB
$2.09B
| $793K | 0.02% |
+10,290
| New | +$664K |
2016 Q1
0 quarters
|
|
308
SPS Commerce
SPSC
$3.13B
| $784K | 0.02% |
36,526
-36,894
| -50% | -$926K |
2013 Q2
11 quarters
|
|
309
Simon Property Group
SPG
$65.8B
| $783K | 0.02% |
3,772
+150
| +4% | +$28.8K |
2013 Q2
11 quarters
|
|
310
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
| $781K | 0.02% |
30,639
-17,856
| -37% | -$374K |
2014 Q3
6 quarters
|
|
311
Vanguard S&P 500 ETF
VOO
$1.05T
| $780K | 0.02% |
4,136
+366
| +10% | +$65.5K |
2014 Q1
8 quarters
|
|
|
BXLT
312
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $772K | 0.02% |
19,098
-2,225
| -10% | -$88K |
2015 Q3
2 quarters
|
|
313
Huntington Ingalls Industries
HII
$10.5B
| $757K | 0.02% |
+5,527
| New | +$719K |
2016 Q1
0 quarters
|
|
314
Fiserv Inc
FISV
$25.1B
| $754K | 0.02% |
14,702
+1,242
| +9% | +$58.9K |
2013 Q2
11 quarters
|
|
315
SEI Investments
SEIC
$12.6B
| $753K | 0.02% |
17,499
-12,951
| -43% | -$531K |
2015 Q4
1 quarter
|
|
316
Oxford Industries
OXM
$418M
| $752K | 0.02% |
+11,192
| New | +$762K |
2016 Q1
0 quarters
|
|
317
Alliant Energy
LNT
$17.4B
| $750K | 0.02% |
20,196
+164
| +0.8% | +$5.53K |
2013 Q2
11 quarters
|
|
|
IMPV
318
DELISTED
Imperva, Inc.
IMPV
| $744K | 0.02% |
14,723
-10,308
| -41% | -$496K |
2014 Q4
5 quarters
|
|
319
Ares Capital
ARCC
$13.6B
| $743K | 0.01% |
50,041
-7,146
| -12% | -$98.4K |
2014 Q1
8 quarters
|
|
320
Duke Energy
DUK
$92.7B
| $736K | 0.01% |
9,125
+915
| +11% | +$69.2K |
2013 Q2
11 quarters
|
|
321
Aflac
AFL
$59.2B
| $723K | 0.01% |
22,896
+2,220
| +11% | +$65.9K |
2013 Q4
9 quarters
|
|
322
Devon Energy
DVN
$54.2B
| $722K | 0.01% |
26,296
+12,900
| +96% | +$314K |
2013 Q2
11 quarters
|
|
323
Precigen
PGEN
$2.58B
| $718K | 0.01% |
+21,371
| New | +$673K |
2016 Q1
0 quarters
|
|
|
CLA.CL
324
DELISTED
Capitala Finance Corp.
CLA.CL
| $716K | 0.01% |
28,900
+1,600
| +6% | +$38.9K |
2014 Q2
7 quarters
|
|
|
TRIB
325
Trinity Biotech
TRIB
$6.45M
| $702K | 0.01% |
401
| – | – |
2013 Q2
11 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q1 2016 Portfolio in Review
As of Q1 2016, Geneva Advisors held 802 positions worth $4.97B, down 4.4% from $5.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Geneva Advisors's Q1 2016 filing shows 109 new, 252 increased, 267 reduced and 54 closed positions. Its largest new stake was Ventas: 517,036 shares worth $32.6M. The largest sale was ServiceNow, an estimated $44M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Technology.
- Geneva Advisors's largest Q1 2016 buy was Ventas: 517,036 shares worth $32.6M.
- Geneva Advisors added most to Bristol-Myers Squibb in Q1 2016, an estimated $28.3M increase.
- Geneva Advisors's biggest Q1 2016 reduction was SBA Communications, cutting an estimated $43.3M.
- Geneva Advisors fully exited ServiceNow in Q1 2016, selling an estimated $44M.
- Geneva Advisors's ten largest holdings make up 25% of its $4.97B portfolio in Q1 2016.
- Geneva Advisors opened 109 new positions and closed 54 in Q1 2016.
- Geneva Advisors's portfolio value fell 4.4% quarter-over-quarter to $4.97B.
Based on Geneva Advisors's 13F filing for Q1 2016, filed 3 May 2016.